Behind the headlines: Pfizer scales back investment but hope remains for a...
Recent news from the pharmaceutical industry that Pfizer is reducing its investment in dementia research has highlighted some of the barriers to research, and the increased need for shared...
View ArticleAlcohol and dementia risk – what we know so far
You may have seen reports in today’s papers about a link between long-term alcohol misuse and risk of dementia. This study published in the Lancet found: That alcohol misuse is linked to an increased...
View ArticleLaunching the Dementia Revolution
Today, we’ve announced that we’re joining forces with Alzheimer’s Society for a special one-year campaign as Charity of the Year for the 2019 Virgin Money London Marathon. On behalf of myself and the...
View ArticlePrime Minister supports revolutionary early diagnosis effort
In an announcement made today, Prime Minister Theresa May outlined a new focus on early diagnosis of disease under the Grand Challenge on Artificial Intelligence in the Industrial Strategy. The Prime...
View Article4 emerging non-drug approaches to tackle dementia
When we think about future treatments for dementia our minds may immediately think of new drugs. From vaccines to antibiotics, aspirin to statins, drugs have had a revolutionary impact on our health...
View ArticleIn the news: Alzheimer’s drug trial set back
We’ve heard disappointing news that the pharmaceutical companies Biogen and Eisai have halted two trials of the experimental Alzheimer’s drug, aducanumab. Early stage clinical trials of aducanumab had...
View ArticleCould the answers to dementia be hiding in your fruit bowl?
Imagine it’s a hot summer’s day and you are relaxing in the garden. Maybe you’re sipping on a glass of cool lemonade, savouring uncharacteristically good British weather. Everything is perfect, until...
View ArticleBehind the headlines: Football and dementia
Scientists have today announced results from the Football’s InfluencE on Lifelong Health and Dementia Risk (FIELD) study. This is the largest study to date looking back at the long-term health of...
View ArticleBehind the headlines: Is a new Alzheimer’s treatment in sight?
You may have seen exciting headlines about a possible new treatment for Alzheimer’s disease. But with so many stories about possible new dementia drugs making the news it can be difficult to know how...
View ArticleCan we really reduce the number of people living with dementia by 40%?
Understanding dementia risk is a complex task. There are lots of different factors that can contribute to a person’s risk and these can sometimes interact with each other in ways that are difficult to...
View Article